microRNA-205 in prostate cancer: Overview to clinical translation - PubMed
pubmed.ncbi.nlm.nih.gov · saved by 1 readers
Prostate cancer (PrCa) is the most common type of cancer among men in the United States. The metastatic and advanced PrCa develops drug resistance to current regimens which accounts for the poor management. microRNAs (miRNAs) have been well-documented for their diagnostic, prognostic, and therapeuti …